New Findings on PTRH2 Gene Variants in a Rare Genetic Disease
Author Information
Author(s): Rajech Sharkia, Marie-Laure Vuillaume, Sahil Jain, Muhammad Mahajnah, Radka Stoeva, Agnès Guichet, Estelle Colin, Jérome Champ, Nicolas Derive, Arnaud Chefdor, Abdelnaser Zalan, Stefano Lonardi
Primary Institution: Unit of Human Biology and Genetics, The Triangle Regional Research and Development Center, Kafr Qari, Israel
Hypothesis
What are the clinical features and genetic variants associated with IMNEPD?
Conclusion
The study highlights the variability in clinical presentation of IMNEPD and identifies Q85 as a potential mutational hotspot in the PTRH2 protein.
Supporting Evidence
- Motor delay, neuropathy, and intellectual disability are common symptoms in IMNEPD.
- Q85R mutation significantly impairs the stability and functionality of the PTRH2 protein.
- Behavioral difficulties such as self-mutilation and picky eating were observed in the studied cases.
Takeaway
This study looks at a rare disease caused by changes in a specific gene, showing that symptoms can be very different for each person.
Methodology
Clinical examination and genome sequencing were performed, along with bioinformatics analysis of PTRH2 mutations.
Limitations
The study is limited by the small sample size and the variability in clinical features among patients.
Participant Demographics
Two siblings of Arab Syrian origin living in France.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website